A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2018
At a glance
- Drugs Bermekimab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Cachexia; Pancreatic cancer
- Focus Adverse reactions
- 31 Oct 2018 According to an XBiotech media release, enrollment is expected to complete in end 2018.
- 04 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 31 Aug 2018 Biomarkers information updated